ACLY and metabolic dysfunction-associated steatotic liver disease: A more recent study demonstrated that EA ameliorates high fructose-induced hyperuricemia and NAFLD through activation of C1q/tumour necrosis factor-related protein (CTRP3) and inhibition of ATP citrate lyase (ACL) in male albino rats [196].